Serial 98095927
Live / Applied — Statement of use — registration review complete (as of 30 Mar 2026)
What this means for you
Not registered yet, but its 21 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98095927
- Mark type
- Design / logo
- Filed
- 21 Jul 2023
- Published for opposition
- 07 May 2024
- Attorney of record
- Michael R. Graif
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disorders, ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of viral infections; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations, namely, antivirals
Owner
- Crossbow Therapeutics, Inc., Cambridge, MA, US
- Crossbow Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 30 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Sept 2025 — USE AMENDMENT FILED
- 28 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 01 Aug 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 01 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 May 2025 — SOU EXTENSION 2 GRANTED
- 02 May 2025 — SOU EXTENSION 2 FILED
- 02 May 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED